F4 FundFund
TeamPortfolioRaiseEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesFrequent co-investorsSimilar Firms
Warm Fund

Meach Cove Capital

meachcovecapital.com · Cambridge, MA

Investment thesis

Invest in entrepreneurs finding the gaps to produce higher quality food for more people at lower cost with less damage to the environment.

Follows
Lead Tendency
01Investment Thesis

Invest in entrepreneurs finding the gaps to produce higher quality food for more people at lower cost with less damage to the environment.

02Investment Team
HK
Harris Komishane
General Partner
KZ
Ken Zolot
General Partner
JK
James K. Cornell
General Partner
03F4 Research Brief

Meach Cove Capital Research

Investment Thesis

Meach Cove Capital is an early-stage venture firm based in Cambridge, Massachusetts, founded in 2022. It backs founders with disruptive ideas in food and agriculture. Its stated focus is entrepreneurs who find the gaps that let the world produce higher quality food for more people, at lower cost and with less damage to the environment. The firm frames this as a response to some of the world's largest challenges being solved through innovation in food and agriculture.

The firm was inspired by John Abele, co-founder of Boston Scientific, who is a limited partner in the fund and guides its focus. Abele owns Meach Cove Farms in Shelburne, Vermont, a 1,000-acre certified organic farm growing soybeans, hay, wheat, rye, corn and wine grapes, with 350 acres of woodland, a solar array and on-farm work on biomass alternatives to petroleum fuel.

Focus Areas

Meach Cove names four areas on its site:

  • Innovative farming, including crop microbiomes, mycorrhizal inoculants, crop breeding and irrigation management
  • Alternative foods, including cell-cultured chocolate and coffee, animal-free dairy, koji-based and mushroom-hybrid foods, and functional proteins from algae
  • Biomaterials, including next-generation oils, continuous fermentation and biomanufacturing capacity
  • Personalized nutrition, including enzymes that change how the body uses food

The portfolio leans heavily on biology: computationally designed organisms, optogenetic cell control, protein discovery platforms, and animal health vaccines for bees and shrimp.

Stage Focus

Meach Cove describes itself as early-stage. Its disclosed rounds span seed and pre-seed through Series B, with participation in a convertible-note round for biomanufacturing capacity. Most of its public rounds are seed-stage or later venture rounds where it joined a syndicate.

Check Size and Lead Tendency

The firm does not publish a check size or fund size. In the rounds it has announced publicly (Dalan Animal Health, EdiMembre, Liberation Labs, Shiru), it participated alongside other investors and was not named as lead. Founders should expect to bring or find a lead investor and ask the partners directly how much they invest.

Recent Activity

  • May 2026: Seed round in Sond, a $7M round with Crosslink Capital, Alumni Ventures, E14 Fund and Ubiquity Ventures
  • November 2025: Participated in Dalan Animal Health's $3M seed (shrimp vaccine commercialization)
  • August 2025: Participated in EdiMembre's pre-seed with Siddhi Capital and Replicator VC (edible bioreactor membranes for cultivated meat)
  • January 2025: Participated in Liberation Labs' $50.5M convertible-note round to complete its precision-fermentation plant in Richmond, Indiana
  • November 2024: Participated in Shiru's $16M Series B with S2G Ventures, CPT Capital, Lux Capital and Nourish Ventures

The firm appears to be actively investing, with its most recent known deal in May 2026.

Portfolio Highlights

The firm's portfolio page lists about two dozen companies, including C16 Biosciences, California Cultured, EdiMembre, Fauna Systems, Ingrediome, Kosterina, Prolific Machines, Robigo, Shiru and Wild Microbes, along with others such as Dalan Animal Health, Liberation Bioindustries, New Culture, Pow.bio, Prime Roots, Treetoscope, Vireo Ag and Zya.

Team

  • Harris Komishane, General Partner: Former Head of Finance & Strategy at Fidelity Investments and member of its operating committee; former CFO/COO of Devonshire Investors, Fidelity's private equity and venture arm; earlier at Coca-Cola and Price Waterhouse; angel investor and advisor on the future of food, sustainable packaging and materials. CFA and CPA.
  • Ken Zolot, General Partner: Teaches innovation and entrepreneurship at MIT; created the Innovation Teams program at MIT's Deshpande Center; co-founded Rethink Robotics and Egenera; advises TechStars, MassChallenge and the Deshpande Foundation.
  • James K. Cornell, General Partner: Managing Partner of Fiduciary Wealth Partners, a multi-family office; former President of Fidelity's Private Wealth Management; active private equity and venture investor.

Decision Process

The firm is run by three general partners. It does not publish its decision process or a pitch channel. A warm introduction through a portfolio founder or co-investor is the likely route in.

Founder Preferences

The firm looks for entrepreneurs with science-led or technology-led approaches to making food and agriculture more productive and less damaging to the environment. Companies in its portfolio tend to have a technical platform, such as fermentation, cell culture, microbiomes or computational design.

Geographic Focus

Meach Cove invests in the United States, and its disclosed portfolio companies are US-based.

04Selected Portfolio
AgTech & Agriculture
Robigo
Biotech & Life Sciences
California Cultured·Prolific Machines·Wild Microbes·Dalan Animal Health·Liberation Labs
Food & Beverage
C16 Bio·Ingrediome·Kosterina·EdiMembre·Shiru
Healthcare & Digital Health
SOND
Robotics & Automation
Fauna Systems
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (5) →
Joined Sond's $7M seed round.
INVESTMENT·capitalatlas.ai
MAY 2026
Participated in Dalan Animal Health's $3M seed to commercialize its shrimp vaccine.
INVESTMENT·excedr.com
NOV 2025
Participated in EdiMembre's pre-seed for edible bioreactor membranes.
INVESTMENT·excedr.com
AUG 2025
Participated in Liberation Labs' $50.5M convertible-note round for its Richmond, Indiana biomanufacturing plant.
INVESTMENT·excedr.com
JAN 2025
Participated in Shiru's $16M Series B.
INVESTMENT·excedr.com
NOV 2024
06Frequent co-investors
AV
Aera VC
Both backed 2 of the same companies
Shiru, Robigo
Find the investors for your round→
07Similar Firms
J
Juniper
$100K – $500K · Pre-Seed · Seed
→
BI
Big Idea Ventures
$125K – $2M · Pre-Seed · Seed
→
I
IndieBio
$500K – $525K · Pre-Seed · Seed
→
FV
FTW Ventures
$500K – $5M · Pre-Seed · Seed
→
RV
Replicator VC
$25K – $250K · Pre-Seed · Seed
→
Quick Reference
Stages
Pre-Seed · Seed · Series A · Series B
Decision
Partnership
Location
Cambridge, MA
Sector Focus
Biotech & Life SciencesFood & BeverageAgTech & Agriculture
Models
Deep TechBiotech Platforms
Technology
Synthetic BiologyFermentationCell CultureMicrobiome
See all Biotech & Life Sciences investors →See all Food & Beverage investors →See all AgTech & Agriculture investors →
Visit meachcovecapital.com ↗

See how Meach Cove Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Biotech & Life SciencesFood & BeverageAgTech & Agriculture

See how Meach Cove Capital matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched November 21, 2026F4 Research Engine